FDA recall D-0417-2025

L'Oreal USA · Class II · drug

Product

La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL. OZ.) Tube per carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, Laboratoire Dermatologique, CAI 86270, La Roche-Posay, France, UPC 883140500759.

Reason for recall

Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.

Distribution

Nationwide in the USA

Key facts

Status
Ongoing
Initiation date
2025-03-05
Report date
2025-05-21
Voluntary/Mandated
Voluntary: Firm initiated
Location
Clark, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0417-2025